ERAS
Erasca (ERAS)
$75
About Erasca (ERAS)
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 1, 2018 and is headquartered in San Diego, CA.
Details
Daily high
$2.78
Daily low
$2.54
Price at open
$2.54
52 Week High
$3.45
52 Week Low
$1.51
Market cap
723.2M
Dividend yield
0.00%
Volume
2.2M
Avg. volume
2.5M
P/E ratio
-2.78
Erasca News
Details
Daily high
$2.78
Daily low
$2.54
Price at open
$2.54
52 Week High
$3.45
52 Week Low
$1.51
Market cap
723.2M
Dividend yield
0.00%
Volume
2.2M
Avg. volume
2.5M
P/E ratio
-2.78